# Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

> **NCT00000585** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Anemia, Sickle Cell
- Hematologic Diseases
- Hemoglobinopathies
- Infection (S. Pneumoniae)
- Pneumonia

## Interventions

- **DRUG:** penicillin

## Key facts

- **NCT ID:** NCT00000585
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1983-08
- **Primary completion:** —
- **Final completion:** 1994-10
- **Target enrollment:** — (—)
- **Last updated:** 2016-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000585, "Penicillin Prophylaxis in Sickle Cell Disease (PROPS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*